Timber Pharmaceuticals Files Chapter 11 Bankruptcy in Delaware

Timber Pharmaceuticals LLC and affiliate Timber Pharmaceuticals Inc. filed for Chapter 11 protection from creditors in Delaware on Friday.

• The publicly traded medical dermatology company was founded in 2019 and focuses on rare skin diseases, according to its website
• Timber Pharmaceuticals LLC listed assets of no more than $10 million and liabilities of at least that amount in its bankruptcy petition

To contact the reporter on this story:
Jeremy Hill in New York at jhill273@bloomberg.net

To contact the editors responsible for this story:
Claire Boston at cboston6@bloomberg.net

Michael B. Marois

© 2023 Bloomberg L.P. All rights reserved. Used with permission. ...